Skip to main content

Table 1 Patient baseline characteristics of the entire cohort

From: Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma

Variables  
Median age (range), years 55 (25–77)
Median body mass index (range), kg/m2 22.7 (15.0–32.9)
Site of disease
 Ovary (%) 144 (96%)
 Fallopian tube/peritoneum (%) 6 (4%)
Neo-adjuvant chemotherapy (%) 14 (9.3%)
Preoperative laboratory values
 Median CA-125 (range), U/mL 1166 (57–5502)
 Median total protein (range), g/dL 7.1 (4.1–9.6)
 Median albumin (range), g/dL 3.9 (2.4–8.2)
Tumor stage
 IIIC (%) 114 (76%)
 IV (%) 36 (24%)
Histology
 Serous (%) 134 (89.3%)
 Non-serous (%) 16 (10.7%)
Presence of pleural effusion before surgery (%) 47 (31.3%)
 Right 9 (6.0%)
 Left 9 (6.0%)
 Bilateral 29 (19.3%)
Preoperative pleural drainage (%) 7 (4.7%)
Presence of ascites at surgery (%) 141 (94%)
Median ascites volume (range), mL 2000 (20–7300)
Type of diaphragm surgery
 Diaphragm peritonectomy (%) 124 (82.7%)
 Diaphragm full-thickness resection (%) 26 (17.3%)
  1. Abbreviations: CA-125 cancer antigen 125